Testim® 1% testosterone gel for the treatment of male hypogonadism

Clinical Therapeutics

Volumn 27, Issue 3, 2005, Pages 286-298

  Bouloux, Pierre ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Aging male; Androgen therapy; Male hypogonadisml lateonset hypogonadism; Testim; Testosterone; Testosterone deficiency; Testosterone gel; Testosterone replacement therapy; Testosterone therapy

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; CORTICOTROPIN; HEMOGLOBIN; PLACEBO; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ANDROGEN THERAPY; AREA UNDER THE CURVE; BODY COMPOSITION; BODY FAT; BONE DENSITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; EDEMA; EMBASE; ERYTHEMA; GEL; GYNECOMASTIA; HEMATOCRIT; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOGONADISM; INSOMNIA; LEAN BODY WEIGHT; LIVER TOXICITY; MEDICAL LITERATURE; MEDLINE; MOOD DISORDER; MOTIVATION; PENIS ERECTION; PROSTATE CANCER; PUBLICATION; REVIEW; SCORING SYSTEM; SEXUAL BEHAVIOR; SIDE EFFECT; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; DRUG ADMINISTRATION; INTRADERMAL DRUG ADMINISTRATION; MALE;

ADMINISTRATION, CUTANEOUS; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; GELS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; TESTOSTERONE;

EID: 18844387949     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.dinthera.2005.02.015     Document Type: Article

References (33)

1. American Association of Clinical Endocrinologists American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update Endocr Pract. 8 2002 440 456
2. Morales A., Heaton J.P., and Carson C.C. III Andropause: A misnomer for a true clinical entity J Urol. 163 2000 705 712
3. Morales A., Lunenfeld B., and International Society for the Study of the Aging Male Investigation, treatment and monitoring of lateonset hypogonadism in males. Official recommendations of ISSAM Aging Male. 5 2002 74 86
4. Griffen J.E., and Wilson J.D. Disorders of the testes Fauci A.S. Braunwald E. Isselbacher K.J. Harrison's Principles of Internal Medicine 14th ed. 1998 McGraw-Hill New York 2087 2097
5. Matsumoto A.M. Andropause: Clinical implications of the decline in serum testosterone levels with aging in men J Gerontol A Biol Sci Med Sci. 57 2002 M76 M99
6. Swerdloff R.S., and Wang C. Androgens and the ageing male Best Pract Res Clin Endocrinol Metab. 18 2004 349 362
7. Allan C.A., and McLachlan R.I. Age-related changes in testosterone and the role of replacement therapy in older men Clin Endocrinol (Oxf) 60 2004 653 670
8. Harman S.M., Metter E.J., and Tobin J.D. Baltimore Longitudinal Study of Aging Longitudinal effects of aging on serum total and free testosterone levels in healthy men J Clin Endocrinol Metab. 86 2001 724 731
9. Liu P.Y., Swerdloff R.S., and Veldhuis J.D. Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: Future research and current practice recommendations J Clin Endocrinol Metab. 89 2004 4789 4796
10. Asnani S., Cefalu C.A., and Naval-Srinivas R.M. Testosterone replacement in the elderly: A clinical approach Ann Long Term Care. 11 2003 44 50
11. Oettel M. The endocrine pharmacology of testosterone therapy in men Naturwissenschaften. 91 2004 66 76
12. Heaton J.P., and Morales A. Endocrine causes of impotence (nondiabetes) Urol Clin North Am. 30 2003 73 81
13. Testim 1% Gel [summary of product characteristics-full prescribing information] 2003 Auxilium UK Windsor, UK
14. Hayes F.J. Androgen replacement in the male: Recent studies Curr Opin Endocrinol Diabetes 8 2001 301 306
15. Basaria S., and Dobs A.S. New modalities of transdermal testosterone replacement Treat Endocrinol. 2 2003 1 9
16. Brawer M.K. Testosterone replacement in men with andropause: An overview. Rev Urol. 6 Suppl 6 2004 S9 S15
17. Rhoden E.L., and Morgentaler A. Risks of testosterone-replacement therapy and recommendations for moni toring N Engl J Med. 350 2004 482 492
18. Marbury T., Hamill E., and Bachand R. Evaluation of the pharmacokinetic profiles of the new testoster one topical gel formulation, Testim™, compared to AndroGel® Biopharm Drug Dispos. 24 2003 115 120
19. McNicholas T.A., Dean J.D., and Mulder H. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function BJU Int. 91 2003 6974
20. Steidle C., Schwartz S., Jacoby K. North American AA2500 T Gel Study Group AA2500 testos terone gel normalizes androgen levels in aging males with improvements in body composition and sexual function J Clin Endocrinol Metab. 88 2003 2673 2681
21. Dean J.D., Carnegie C., Rodzvilla J. Jr, and Smith T. Long-term effects of Testim® 1% testosterone gel in hypogonadalmen Rev Urol. 6 Suppl 6 2004 S22 S29
22. Loizides E., Swierzewski M.J., and O'Neill C. Early response time in sexual activity and mood following testos terone gel replacement in hypogonadal males from the Testim® START study Rev Urol. 6 Suppl 6 2004 S16 S21
23. Lee K.K., Berman N., and Alexander G.M. A simple self-report diary for assessing psychosexual function in hypogonadal men J Androl. 24 2003 688 698
24. Wang C., Swedloff R.S., Iranmanesh A. Testosterone Gel Study Group Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men J Clin Endocrinol Metal. 85 2000 2839 2853
25. Arver S., Dobs A.S., and Meikle A.W. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men Clin Endocrinol (Oxf) 47 1997 727 737
26. Wang C., Alexander G., and Berman M. Testosterone replacement therapy improves mood in hypogonadal mena clinical research center study J Clin Endocrinol Metab. 81 1996 3578 3583
27. Wasnich R.D., and Miller P.D. Antifracture efficacy of antiresorptive agents are related to changes in bone density J Clin Endocrinol Metab. 85 2000 231 236
28. Asthana S., Bhasin S., and Butler R.N. Masculine vitality: Pros and cons of testosterone in treating the andropause J Gerontol A Biol Sci Med Sci. 59 2004 461 465
29. Malkin C.J., Pugh P.J., and Morris P.D. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life Heart 90 2004 871 876
30. Wu F.C., and von Eckardstein A. Androgens and coronary artery disease Endocr Rev. 24 2003 183 217
31. Cherrier M.M., Asthana S., and Plymate S. Testosterone supplementation improves spatial and verbal memory in healthy older men Neurology 57 2001 80 88
32. O'Connor D.B., Archer J., Hair W.M., and Wu F.C. Activational effects of testosterone on cognitive function in men Neuropsychologia 39 2001 1385 1394
33. SEER Program; 1999. NIH Pub. No. 99-4543 Stanford J.L., Stephenson R.A., and Coyle L.M. Prostate Cancer Trends 1973-1995 National Cancer Institute Bethesda, Md